Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease.
Paul MoayyediEric I BenchimolDavid ArmstrongCathy YuanAida FernandesGrigorios I LeontiadisPublished in: Journal of the Canadian Association of Gastroenterology (2020)
Keyphrases